Federica is a Director at Genextra, she joined in 2006 and since then has been involved in a number of activities ranging from evaluation of new investing opportunities to partnering, licensing as well as strategic development of Genextra’s subsidiary companies.
Federica is also Chief Operating Officer of Congenia s.r.l. and member of the Board of Directors of Erydel S.p.A., two of Genextra’s portfolio companies.
Before joining Genextra, Federica acquired experience in the technology transfer area at Windham Venture Partners, a NYC based life sciences technology commercialization firm, and before that with Science and Technology ventures, Columbia University’s technology transfer office. Prior to that she was a postdoc at the MRC in Cambridge (UK) and she has authored several scientific publications.
Federica holds an MBA from Columbia University and a PhD in Biochemistry from La Sapienza, University of Rome.
